Surgeons' preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ.

ABSTRACT:

Background

There is a large variation between Dutch hospitals in the use of Sentinel Lymph Node Biopsy (SLNB) in patients with a biopsy diagnosis of Ductal Carcinoma in Situ. The aim of our study was to investigate whether this variation might be explained by preferences of surgeons, organisational factors or the influence of patients preferences.

Methods

A cross-sectional web survey was conducted among 260 Dutch oncological/breast surgeons. Preferences of surgeons and the influence of the patients' preferences were determined by means of best-worst scaling (BWS) of profile case scenarios and by ranking risk factors. The survey also explored organisational questions, the reported use of diagnostic techniques and influences on the decision.

Results

The BWS scenarios we

SUBMITTER: Meurs CJC 

PROVIDER: S-EPMC9170095 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature